Atlas Trials

Psoriatic Inflammation Markers Predictive of Response to Adalimumab

Clinical trial NCT03389984 · COMPLETED

Trial details

NCT number
NCT03389984
Sponsor
Poitiers University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Psoriasis Vulgaris
Start date
2017-11-14
Primary completion
2019-11-30
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.